Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New Products Launched At NACDS 2007

This article was originally published in The Tan Sheet

Executive Summary

Matrixx adds syrup, vapor to cold/flu relief: The Zicam cold and sinus product line will be extended with day- and night-time cold and flu syrups and a vapor-action tablet, Matrixx Initiatives announces at the National Association of Chain Drug Store's Marketplace trade show in Boston June 23-26. The syrup products in 8 oz. containers and the Zicam RapidMelts acetaminophen 325 mg and phenylephrine 5 mg tablets will retail at $6.99 each and will be available in stores in August, the Phoenix-based firm says. Matrixx adds the syrup products with a novel delivery system - marketed with the tag line "The Taste You Choose, virtually tasteless when added to any beverage" - to a line that already includes uniquely packaged disposable medicated dosing spoons designed to mix into hot or cold beverages (1"The Tan Sheet" June 13, 2005, p. 6). The day-time formulation contains acetaminophen 325 mg, dextromethorphan 10 mg and guaifenesin 200 mg; the night-time product contains 325 mg acetaminophen, dextromethorphan 10 mg and doxylamine succinate 6.25 mg...

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts